Questions Remain for Ogilvy Following ONDCP Win

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

WASHINGTON — The White House’s decision to retain Ogilvy & Mather, New York, on its $150 million anti-drug media account will likely increase tensions with lawmakers and the Partnership for a Drug-Free America, sources said.

But the win is a big boost for Ogilvy, which has been under fire since the shop became the subject of a federal probe into its billing practices on the account.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in